Ameriprise Financial Inc Travere Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 122,701 shares of TVTX stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
122,701
Previous 602,108 79.62%
Holding current value
$2.27 Million
Previous $4.95 Million 65.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$7.89 - $15.21 $3.78 Million - $7.29 Million
-479,407 Reduced 79.62%
122,701 $1.72 Million
Q2 2024

Aug 14, 2024
BUY
$5.26 - $8.28 $514,364 - $809,684
97,788 Added 19.39%
602,108 $4.95 Million
Q1 2024

May 15, 2024
SELL
$7.18 - $9.82 $368,958 - $504,620
-51,387 Reduced 9.25%
504,320 $3.89 Million
Q4 2023

Feb 14, 2024
BUY
$5.44 - $9.5 $760,909 - $1.33 Million
139,873 Added 33.64%
555,707 $5 Million
Q3 2023

Nov 14, 2023
BUY
$7.64 - $17.25 $1.01 Million - $2.28 Million
132,394 Added 46.71%
415,834 $3.72 Million
Q2 2023

Aug 14, 2023
SELL
$15.3 - $22.61 $557,394 - $823,704
-36,431 Reduced 11.39%
283,440 $4.35 Million
Q1 2023

May 15, 2023
BUY
$17.82 - $22.89 $1.62 Million - $2.08 Million
90,883 Added 39.69%
319,871 $7.19 Million
Q4 2022

Feb 14, 2023
BUY
$18.47 - $26.14 $693,825 - $981,949
37,565 Added 19.62%
228,988 $4.82 Million
Q3 2022

Nov 14, 2022
BUY
$22.91 - $28.63 $4.39 Million - $5.48 Million
191,423 New
191,423 $4.72 Million
Q2 2021

Aug 16, 2021
SELL
$14.11 - $26.4 $331,528 - $620,294
-23,496 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$23.37 - $31.77 $743,563 - $1.01 Million
-31,817 Reduced 57.52%
23,496 $587,000
Q4 2020

Feb 12, 2021
BUY
$19.17 - $27.87 $1.06 Million - $1.54 Million
55,313 New
55,313 $1.51 Million

Others Institutions Holding TVTX

# of Institutions
190
Shares Held
84.7M
Call Options Held
681K
Put Options Held
346K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.19B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email